| Schedule of breakdown of research and development expenses to assess performance and allocate resources |
| | | | | | | | | | | | | | | | Three Months Ended | | Three Months Ended | | Six Months Ended | | Six Months Ended | | | | June 30, 2026 | | June 30, 2025 | | June 30, 2026 | | June 30, 2025 | | Collaboration revenue | | $ | — | | $ | — | | $ | — | | $ | 109,164 | | Less cost and expense: | | | | | | | | | | | | | | Research and development | | | | | | | | | | | | | | Personnel and related costs | | $ | 5,752 | | $ | 9,715 | | $ | 11,348 | | $ | 19,699 | | Facility and other allocated costs | | | 3,589 | | | 5,525 | | | 7,057 | | | 10,847 | | Research and laboratory | | | 9,454 | | | 10,495 | | | 16,922 | | | 19,970 | | Other research and development | | | 800 | | | 1,124 | | | 1,373 | | | 2,923 | | General and administrative | | | 5,787 | | | 7,805 | | | 12,366 | | | 16,212 | | Loss on lease component termination | | | 11,145 | | | — | | | 11,145 | | | — | | Other segment (income) expense | | | (1,977) | | | (2,123) | | | (4,016) | | | (4,506) | | Net income (loss) | | $ | (34,550) | | $ | (32,541) | | $ | (56,195) | | $ | 44,019 | |
|